SBI Securities’s Praxis Precision Medicines PRAX Stock Holding History

SBI Securities’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16.3K	Buy	56 +1	+2%	+$331	﹤0.01%	1644
2026 Q2	$18.4K	Sell	55 -12	-18%	-$3.8K	﹤0.01%	1572
2026 Q1	$21.6K	Sell	67 -7	-9%	-$2.16K	﹤0.01%	1431
2025 Q4	$21.8K	Sell	74 -9	-11%	-$1.68K	﹤0.01%	1407
2025 Q3	$4.4K	Buy	83 +8	+11%	+$388	﹤0.01%	2097
2025 Q2	$3.15K	Buy	75 +10	+15%	+$381	﹤0.01%	2196
2025 Q1	$2.46K	Buy	65 +5	+8%	+$312	﹤0.01%	2205
2024 Q4	$4.62K	Buy	+60	New	+$4.34K	﹤0.01%	1953

Other funds holding PRAX

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Net Worth Advisory Group Sandy, Utah $397M AUM 23.64% 1-Year Est. Return

Eagle Bay Advisors New York $137M AUM 18.51% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

SBI Securities's PRAX Position: Q3 2026 in Review

SBI Securities increased its Praxis Precision Medicines (PRAX) stake by 1.8% in Q3 2026, buying an estimated $331 and bringing the position to 56 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1644.

SBI Securities first reported a position in PRAX in Q4 2024 and has held it in 8 quarters since. The position peaked at $21.8K in Q4 2025. 29 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

SBI Securities held 56 shares of Praxis Precision Medicines worth $16.3K as of Q3 2026.
SBI Securities bought 1 Praxis Precision Medicines share in Q3 2026, an estimated $331.
Praxis Precision Medicines made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #1644 holding.
SBI Securities first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Praxis Precision Medicines position peaked at $21.8K in Q4 2025.
29 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.